NEW YORK (GenomeWeb News) – The Van Andel Research Institute granted GenTel Biosciences exclusive rights to use its technology to commercialize a microarray platform that measures variations in protein glycosylation.
 
GenTel plans to use the technology with its PANDEIAT system to label serum proteins and probe cancer biomarker-specific antibody arrays to measure both the protein abundance and the degree of protein glycosylation, the company said.
 
Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.